Torres T, Mendes-Bastos P, Cruz M, Duarte B, Filipe P, Lopes M
Dermatol Ther (Heidelb). 2025; 15(3):579-597.
PMID: 39930311
DOI: 10.1007/s13555-025-01352-y.
Wang Y, Chen X, Liu C, You C, Xu Y
Metabolomics. 2024; 20(6):131.
PMID: 39537935
DOI: 10.1007/s11306-024-02196-x.
Sid Idris F
Cureus. 2024; 16(9):e69416.
PMID: 39403661
PMC: 11473049.
DOI: 10.7759/cureus.69416.
Sroczyk E, Tarasiuk A, Talar M, Rutledge G, Makaro A, Misztal Z
ACS Appl Mater Interfaces. 2024; 16(29):37783-37794.
PMID: 38994590
PMC: 11284794.
DOI: 10.1021/acsami.4c09400.
Artusa S, Mazzuca G, Piacentini G, Castagnoli R, Marseglia G, Pietrobelli A
Int J Mol Sci. 2024; 25(9).
PMID: 38731996
PMC: 11083669.
DOI: 10.3390/ijms25094778.
Relation Between Reactive Oxygen Species Production and Transient Receptor Potential Vanilloid1 Expression in Human Skin During Aging.
Favero G, Giano M, Franco C, Pinto D, van Noorden C, Rinaldi F
J Histochem Cytochem. 2024; 72(3):157-171.
PMID: 38440794
PMC: 10956443.
DOI: 10.1369/00221554241236537.
JAK-STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review.
Huang I, Chung W, Wu P, Chen C
Front Immunol. 2022; 13:1068260.
PMID: 36569854
PMC: 9773077.
DOI: 10.3389/fimmu.2022.1068260.
OX40-OX40L Inhibition for the Treatment of Atopic Dermatitis-Focus on Rocatinlimab and Amlitelimab.
Le A, Torres T
Pharmaceutics. 2022; 14(12).
PMID: 36559247
PMC: 9787630.
DOI: 10.3390/pharmaceutics14122753.
Efficacy of abrocitinib for atopic dermatitis: a meta-analysis of randomized controlled trials.
Zhang D, He G, Qian T, Hao F, Liu L
Postepy Dermatol Alergol. 2022; 39(5):872-876.
PMID: 36457692
PMC: 9704443.
DOI: 10.5114/ada.2021.110269.
Abrocitinib 100 mg versus 200 mg for atopic dermatitis: a meta-analysis of randomized controlled trials.
Wang J, Yang Y, Yang H, Fu X
Postepy Dermatol Alergol. 2022; 39(5):908-912.
PMID: 36457683
PMC: 9704456.
DOI: 10.5114/ada.2022.114925.
Chronic Pruritus in Atopic Patients Treated with Dupilumab: Real Life Response and Related Parameters in 354 Patients.
Mastorino L, Rosset F, Gelato F, Ortoncelli M, Cavaliere G, Quaglino P
Pharmaceuticals (Basel). 2022; 15(7).
PMID: 35890180
PMC: 9318403.
DOI: 10.3390/ph15070883.
Role of Epithelium-Derived Cytokines in Atopic Dermatitis and Psoriasis: Evidence and Therapeutic Perspectives.
Borgia F, Custurone P, Peterle L, Pioggia G, Gangemi S
Biomolecules. 2021; 11(12).
PMID: 34944487
PMC: 8699296.
DOI: 10.3390/biom11121843.
Interleukin-31 and Pruritic Skin.
Furue M, Furue M
J Clin Med. 2021; 10(9).
PMID: 33924978
PMC: 8124688.
DOI: 10.3390/jcm10091906.
Molecular Mechanisms of Atopic Dermatitis Pathogenesis.
Sroka-Tomaszewska J, Trzeciak M
Int J Mol Sci. 2021; 22(8).
PMID: 33923629
PMC: 8074061.
DOI: 10.3390/ijms22084130.
Increased Prevalence of Face Mask-Induced Itch in Health Care Workers.
Krajewski P, Matusiak L, Szepietowska M, Bialynicki-Birula R, Szepietowski J
Biology (Basel). 2020; 9(12).
PMID: 33297438
PMC: 7762243.
DOI: 10.3390/biology9120451.
Regulation of Skin Barrier Function via Competition between AHR Axis versus IL-13/IL-4‒JAK‒STAT6/STAT3 Axis: Pathogenic and Therapeutic Implications in Atopic Dermatitis.
Furue M
J Clin Med. 2020; 9(11).
PMID: 33233866
PMC: 7700181.
DOI: 10.3390/jcm9113741.
Pain in Atopic Dermatitis: An Online Population-based Survey.
Huet F, Shourick J, Seite S, Taieb C, Misery L
Acta Derm Venereol. 2020; 100(14):adv00198.
PMID: 32424431
PMC: 9199926.
DOI: 10.2340/00015555-3521.
Aryl Hydrocarbon Receptor Activation Downregulates IL-33 Expression in Keratinocytes via Ovo-Like 1.
Tsuji G, Hashimoto-Hachiya A, Yen V, Miake S, Takemura M, Mitamura Y
J Clin Med. 2020; 9(3).
PMID: 32214018
PMC: 7141508.
DOI: 10.3390/jcm9030891.
Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis: A Phase 2b Randomized Clinical Trial.
Guttman-Yassky E, Blauvelt A, Eichenfield L, Paller A, Armstrong A, Drew J
JAMA Dermatol. 2020; 156(4):411-420.
PMID: 32101256
PMC: 7142380.
DOI: 10.1001/jamadermatol.2020.0079.
Pruritus in pediatric patients with atopic dermatitis: a multidisciplinary approach - summary document from an Italian expert group.
El Hachem M, Di Mauro G, Rotunno R, Giancristoforo S, De Ranieri C, Carlevaris C
Ital J Pediatr. 2020; 46(1):11.
PMID: 32000823
PMC: 6993480.
DOI: 10.1186/s13052-020-0777-9.